Divi's Laboratories Ltd DIVISLAB-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:22 PM IST
3,496.90quote price arrow down-56.55 (-1.59%)
Volume
390,702
52 week range
1,626.00 - 3,914.95

...

Loading . . .

KEY STATS

  • Open3,518.00
  • Day High3,550.00
  • Day Low3,490.00
  • Prev Close3,553.45
  • 52 Week High3,914.95
  • 52 Week High Date01/04/21
  • 52 Week Low1,626.00
  • 52 Week Low Date03/13/20
  • Market Cap12,096.56M
  • Shares Out265.45M
  • 10 Day Average Volume748,461.18
  • Dividend24.00
  • Dividend Yield0.69%
  • Beta
  • 1 Year % Change57.38

RATIOS/PROFITABILITY

  • EPS (TTM)70.46
  • P/E (TTM)49.63
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/25/2020
  • Div Amount16.00
  • Split Date-
  • Split Factor-

Latest Divi's Laboratories Ltd News

There is no recent news for this security.

Latest DIVISLAB-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. The Company's geographical segments include India (Sales to customers within India) and other countries (Sales to customers outside India). Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids. It is also involved in developing alternate, non-infringing processes for APIs, for the inventors to manage late life...
Murali Divi
Chairman
Ramesh Nimmagadda
Non-Executive Chairman
Kiran Divi
Chief Executive Officer
L. Kishore Babu
Chief Financial Officer
Address
1-72/23(P)/Divis/303
, Divi Towers, Cyber Hills, Gachibowli,
Hyderabad
500032
India